Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.
Type:
Grant
Filed:
August 18, 2016
Date of Patent:
April 12, 2022
Assignee:
Amicrobe, Inc.
Inventors:
Michael P. Bevilacqua, Diego Benitez, Jarrod A. Hanson
Abstract: The present invention relates to an antimicrobial pharmaceutical composition, comprising an aqueous carrier, and an antimicrobial synthetic cationic polypeptide(s) dispersed in the aqueous carrier at a concentration in the range of about 0.01% to about 5%, by weight based on total weight of the antimicrobial pharmaceutical composition, wherein the antimicrobial synthetic cationic polypeptide(s) comprises a plurality of positively charged amino acid units at neutral pH, and fulfils certain viscosity and toxicity requirements. The invention further relates to a method of preventing microbial contamination of tissues other than intact, healthy skin, comprising administering the present antimicrobial pharmaceutical composition in an amount effective to at least partially protect the tissue site from becoming contaminated with microbes.
Type:
Grant
Filed:
April 5, 2018
Date of Patent:
March 29, 2022
Assignee:
AMICROBE, INC.
Inventors:
Michael P. Bevilacqua, Daniel J. Huang, Doug Looker
Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
Type:
Grant
Filed:
April 22, 2015
Date of Patent:
October 22, 2019
Assignees:
The Regents of the University of California, Amicrobe, Inc.
Inventors:
Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
September 20, 2016
Assignee:
AMICROBE, INC.
Inventors:
Michael P. Bevilacqua, Diego Benitez, Jarrod A. Hanson
Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
Type:
Grant
Filed:
February 25, 2013
Date of Patent:
April 28, 2015
Assignees:
The Regents of the University of California, Amicrobe, Inc.
Inventors:
Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
Type:
Application
Filed:
February 25, 2013
Publication date:
October 10, 2013
Applicants:
Amicrobe, Inc., The Regents of the University of California
Inventors:
Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol